Welcome to Central Library, SUST

Innovative drug synthesis / (Record no. 65597)

MARC details
000 -LEADER
fixed length control field 03286cam a2200685 i 4500
001 - CONTROL NUMBER
control field sulb-eb0033945
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221423.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150623s2015 nju ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2015025120
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
Language of cataloging eng
Description conventions rda
Transcribing agency DLC
Modifying agency OCLCF
-- N$T
-- IDEBK
-- DG1
-- CDX
-- COO
-- YDXCP
-- DEBBG
-- RECBK
-- BD-SySUS
019 ## -
-- 931157870
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118820025 (pdf)
International Standard Book Number 1118820029 (pdf)
International Standard Book Number 9781118820087 (epub)
International Standard Book Number 1118820088 (epub)
Canceled/invalid ISBN 9781118820056 (cloth)
International Standard Book Number 9781118819951
International Standard Book Number 1118819950
International Standard Book Number 1118820053 (cloth)
International Standard Book Number 9781118820056 (cloth)
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier GBVCP
System control number 845212419
OCLC library identifier DEBBG
System control number BV043738005
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)911618038
Canceled/invalid control number (OCoLC)931157870
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS420
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/9
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Innovative drug synthesis /
Statement of responsibility, etc. edited by Jie Jack Li, Douglas S. Johnson.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Hoboken, New Jersey :
Name of producer, publisher, distributor, manufacturer Wiley,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Source rdacarrier
490 0# - SERIES STATEMENT
Series statement Drug synthesis series
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record and CIP data provided by publisher.
520 ## - SUMMARY, ETC.
Summary, etc. This book covers all aspects of the medicinal chemistry of the latest drugs, and the cutting-edge science associated with them. Following the editors' 3 successful drug synthesis books, this provides expert analysis of the pros and cons of different synthetic routes and demystifies the process of modern drug discovery for practitioners and researchers. -Summarizes for each drug: respective disease area, important properties and SAR (structure-activity relationship), and chemical synthesis routes / options -Includes case studies in each chapter -Illustrates how chemistry, biology, pharmacokinetics, and a host of disciplines come together to produce successful medicines -Explains the advantages of process synthesis versus the synthetic route for drug discovery
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Design.
Topical term or geographic name as entry element Pharmaceutical chemistry.
Topical term or geographic name as entry element Drugs
General subdivision Design.
Source of heading or term fast
Authority record control number (OCoLC)fst00898790
Topical term or geographic name as entry element Pharmaceutical chemistry.
Source of heading or term fast
Authority record control number (OCoLC)fst01060115
Topical term or geographic name as entry element MEDICAL / Pharmacology
Source of heading or term bisacsh
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Jie Jack,
Relator term editor.
Personal name Johnson, Douglas S.
Fuller form of name (Douglas Scott),
Dates associated with a name 1968-
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Innovative drug synthesis
Place, publisher, and date of publication Hoboken, New Jersey : John Wiley & Sons, 2015
International Standard Book Number 9781118820056
Record control number (DLC) 2015022461
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9781118819951">http://onlinelibrary.wiley.com/book/10.1002/9781118819951</a>
Public note Wiley Online Library [Free Download only for SUST IP]
938 ## -
-- Recorded Books, LLC
-- RECE
-- rbeEB00665966
-- EBSCOhost
-- EBSC
-- 1095570
-- Ingram Digital eBook Collection
-- IDEB
-- cis30531392
-- Coutts Information Services
-- COUT
-- 30531392
-- YBP Library Services
-- YANK
-- 12726610
-- YBP Library Services
-- YANK
-- 11072742
-- YBP Library Services
-- YANK
-- 13035642
994 ## -
-- 92
-- DG1

No items available.